Nutritional management during chemotherapy and chemoradiotherapy for advanced esophageal cancer.

Yutaka Kimura, Atsushi Gakuhara, Shuichi Fukuda, Yasunari Fukuda, Terukazu Yoshihara, Chikato Koga, Naotsugu Haraguchi, Jin-Ichi Hida
Author Information
  1. Yutaka Kimura: Department of Surgery, Kindai University Nara Hospital, 1248-1 Otoda-Cho, Ikoma, Nara, 630-0293, Japan. you_kimura@aol.com. ORCID
  2. Atsushi Gakuhara: Department of Surgery, Kindai University Nara Hospital, 1248-1 Otoda-Cho, Ikoma, Nara, 630-0293, Japan.
  3. Shuichi Fukuda: Department of Surgery, Kindai University Nara Hospital, 1248-1 Otoda-Cho, Ikoma, Nara, 630-0293, Japan.
  4. Yasunari Fukuda: Department of Surgery, Kindai University Nara Hospital, 1248-1 Otoda-Cho, Ikoma, Nara, 630-0293, Japan.
  5. Terukazu Yoshihara: Department of Surgery, Kindai University Nara Hospital, 1248-1 Otoda-Cho, Ikoma, Nara, 630-0293, Japan.
  6. Chikato Koga: Department of Surgery, Kindai University Nara Hospital, 1248-1 Otoda-Cho, Ikoma, Nara, 630-0293, Japan.
  7. Naotsugu Haraguchi: Department of Surgery, Kindai University Nara Hospital, 1248-1 Otoda-Cho, Ikoma, Nara, 630-0293, Japan.
  8. Jin-Ichi Hida: Department of Surgery, Kindai University Nara Hospital, 1248-1 Otoda-Cho, Ikoma, Nara, 630-0293, Japan.

Abstract

Advanced esophageal cancer is treated by chemotherapy, radiation therapy, chemoradiotherapy, and immunotherapy. However, the stenosis caused by the tumor and cancer-related chronic inflammation leads to inadequate food intake, weight loss, and nutrition problems. Given that poor pre-treatment nutritional status increases the risks of treatment-related adverse events and a poor prognosis, the nutrition guidelines recommend a pre-treatment nutritional assessment. When malnutrition is present, nutritional interventions, such as dietary guidance and enteral nutrition supplements, provided by the medical team may reduce treatment-related adverse events. However, whether nutritional intervention improves the prognosis is a topic for future research, including randomized controlled trials. This review discusses the literature on nutritional management in patients undergoing chemotherapy and chemoradiotherapy for advanced esophageal cancer.

Keywords

References

Cancer Res Treat. 2022 Apr;54(2):505-516 [PMID: 34176250]
ESMO Open. 2021 Oct;6(5):100277 [PMID: 34626918]
BMC Cancer. 2019 Oct 26;19(1):1004 [PMID: 31655563]
Jpn J Clin Oncol. 2019 Oct 1;49(10):910-918 [PMID: 31219161]
Front Oncol. 2022 Apr 13;12:834564 [PMID: 35494073]
Oncol Lett. 2022 Jun 14;24(2):257 [PMID: 35765281]
J Cachexia Sarcopenia Muscle. 2019 Feb;10(1):199-206 [PMID: 30666831]
Nutr Cancer. 2018 Apr;70(3):447-452 [PMID: 29521534]
Clin Nutr. 2021 May;40(5):2898-2913 [PMID: 33946039]
Nutrients. 2023 Feb 27;15(5): [PMID: 36904192]
Radiat Oncol. 2020 May 22;15(1):116 [PMID: 32443967]
Nutrition. 2020 Jan;69:110558 [PMID: 31526964]
Clin Nutr. 2022 May;41(5):1112-1121 [PMID: 35413573]
Anticancer Res. 2017 Jun;37(6):3053-3059 [PMID: 28551644]
Oncotarget. 2017 Aug 24;8(44):77465-77473 [PMID: 29100401]
Clin Nutr ESPEN. 2022 Jun;49:172-180 [PMID: 35623809]
BMC Gastroenterol. 2022 Apr 30;22(1):211 [PMID: 35501704]
J Clin Med. 2019 Oct 09;8(10): [PMID: 31601040]
Lancet Oncol. 2005 May;6(5):334-43 [PMID: 15863382]
Esophagus. 2021 Apr;18(2):296-305 [PMID: 33009977]
Surgery. 2019 Dec;166(6):1041-1047 [PMID: 31607486]
Dis Esophagus. 2014 Nov-Dec;27(8):737-43 [PMID: 24917486]
Br J Cancer. 2006 Mar 13;94(5):637-41 [PMID: 16479253]
Dig Liver Dis. 2014 Sep;46(9):846-53 [PMID: 24970014]
Ann Surg Oncol. 2019 Dec;26(13):4754-4764 [PMID: 31452051]
Dis Esophagus. 2023 Jan 28;36(2): [PMID: 35795994]
J Immunother. 2022 Nov-Dec 01;45(9):415-422 [PMID: 36006239]
Anticancer Res. 2019 Oct;39(10):5675-5682 [PMID: 31570466]
Nutr Cancer. 2021;73(10):1933-1940 [PMID: 33044092]
Cancer Manag Res. 2019 Nov 06;11:9459-9468 [PMID: 31819611]
In Vivo. 2023 Jan-Feb;37(1):22-35 [PMID: 36593006]
Eur J Surg Oncol. 2015 Mar;41(3):333-8 [PMID: 25498359]
Curr Oncol. 2023 Jan 24;30(2):1538-1545 [PMID: 36826079]
J Clin Oncol. 2015 Jan 1;33(1):90-9 [PMID: 25422490]
Oncologist. 2015 Oct;20(10):1216-22 [PMID: 26341759]
Clin Nutr. 2012 Jun;31(3):330-6 [PMID: 22169459]
Curr Oncol. 2022 Nov 17;29(11):8825-8834 [PMID: 36421347]
Sci Rep. 2021 Mar 23;11(1):6644 [PMID: 33758232]
Nutr Cancer. 2018 Aug-Sep;70(6):879-885 [PMID: 30273001]
Clin Nutr. 2016 Jun;35(3):724-30 [PMID: 26065721]
Clin Nutr. 2014 Apr;33(2):204-10 [PMID: 23849811]
In Vivo. 2022 Sep-Oct;36(5):2400-2408 [PMID: 36099141]
Oncol Rep. 2016 Aug;36(2):1093-100 [PMID: 27374272]
Int J Clin Oncol. 2017 Dec;22(6):1042-1049 [PMID: 28717855]
Nutrition. 2017 Jan;33:204-210 [PMID: 27644137]
Clin Nutr. 2021 Jun;40(6):4449-4455 [PMID: 33509666]
Support Care Cancer. 2023 May 17;31(6):341 [PMID: 37195367]
Br J Clin Pharmacol. 2002 Aug;54(2):131-9 [PMID: 12207632]
Br J Cancer. 2016 Jul 12;115(2):172-7 [PMID: 27328311]
In Vivo. 2021 Mar-Apr;35(2):1133-1139 [PMID: 33622911]
Clin Cancer Res. 2007 Jun 1;13(11):3264-8 [PMID: 17545532]
Anticancer Res. 2015 Sep;35(9):4897-901 [PMID: 26254385]
Esophagus. 2023 Jul;20(3):343-372 [PMID: 36933136]
PLoS One. 2023 May 5;18(5):e0285365 [PMID: 37146004]
Clin Nutr. 2021 Jun;40(6):4380-4385 [PMID: 33526287]
Cancer. 2012 Oct 1;118(19):4785-94 [PMID: 22282373]
Radiat Oncol. 2019 Sep 11;14(1):166 [PMID: 31511012]
J Hum Nutr Diet. 2011 Oct;24(5):431-40 [PMID: 21733143]
In Vivo. 2018 May-Jun;32(3):603-610 [PMID: 29695567]
Front Nutr. 2022 Mar 25;9:831283 [PMID: 35399659]
Sci Rep. 2017 Feb 14;7:42581 [PMID: 28195186]
J Cachexia Sarcopenia Muscle. 2022 Dec;13(6):2630-2636 [PMID: 36151845]
Ann Transl Med. 2019 Apr;7(8):175 [PMID: 31168456]
Medicine (Baltimore). 2023 Mar 24;102(12):e33335 [PMID: 36961192]
J Clin Oncol. 2021 Mar 1;39(7):748-756 [PMID: 33417481]
Dis Esophagus. 2016 Nov;29(8):1071-1080 [PMID: 26471766]

MeSH Term

Humans
Esophageal Neoplasms
Chemoradiotherapy
Nutritional Status
Malnutrition
Enteral Nutrition
Nutrition Assessment
Nutritional Support
Prognosis

Word Cloud

Similar Articles

Cited By